BioNTech announces change in legal form...

BioNTech announces change in legal form...

...hires a new Senior Vice President Corporate Development, and appoints a new member of the supervisory board

BioNTech announced that the company intends to change its legal form from a share-based corporation to a European corporation. The new legal form will allow BioNTech to operate on a global level, engage in fundraising transactions and enter into partnerships with other international corporations. 

BioNTech also welcomes Ryan Richardson as Senior Vice President Corporate Development and Strategy and appoints Dr. Ulrich Wandschneider as Member of the Supervisory Board.

For more information, please see the press release in the download area on the right-hand side.

Provider 

Downloads